|
| |
| | | 68477 | | 25.04.2023 | | Bristol-Myers Squibb SA | | | | | | | 24.04.2028 | | | | | | 02.99. | | | | 02.99. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Camzyos 2.5 mg | Hartkapseln | Capsules (Mavacamtenum 2.5 mg) | C01EB24 | CI | | 02 | Camzyos 5 mg | Hartkapseln | Capsules (Mavacamtenum 5 mg) | C01EB24 | | | 03 | Camzyos 10 mg | Hartkapseln | Capsules (Mavacamtenum 10 mg) | C01EB24 | | | 04 | Camzyos 15 mg | Hartkapseln | Capsules (Mavacamtenum 15 mg) | C01EB24 | |
|
|
|
